Literature DB >> 27083104

Nonallergic Rhinitis: Treatment.

Phillip L Lieberman1, Peter Smith2.   

Abstract

Chronic nonallergic rhinitis (NAR) is a syndrome rather than a specific disease. A lack of understanding of the pathogenesis of this condition has led to imprecise terminology with several alternate names for the condition, including vasomotor rhinitis, nonallergic rhinopathy, and idiopathic rhinitis. The therapy for NAR is best based on the underlying pathology, which typically exists in a form whereby an abnormality of the autonomic nervous system is dominant or a form in which inflammation seems to be the cause of symptoms. In general the most effective therapy is the combination of an intranasal antihistamine and an intranasal corticosteroid.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Idiopathic rhinitis; Nonallergic rhinitis; Nonallergic rhinopathy; Noninfectious nonallergic rhinitis; Vasomotor rhinitis

Mesh:

Substances:

Year:  2016        PMID: 27083104     DOI: 10.1016/j.iac.2015.12.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  3 in total

Review 1.  Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management.

Authors:  Dimitri Poddighe; Matteo Gelardi; Amelia Licari; Michele Miraglia Del Giudice; Gian Luigi Marseglia
Journal:  World J Methodol       Date:  2016-12-26

2.  Prevalence of allergic and nonallergic rhinitis in a rural area of northern China based on sensitization to specific aeroallergens.

Authors:  Yuan Zhang; Luo Zhang; Yanran Huang
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-21       Impact factor: 3.406

3.  Developing nomograms for identifying allergic rhinitis among chronic rhinitis: A real-world study.

Authors:  Yanran Huang; Chengshuo Wang; Yuan Zhang; Luo Zhang
Journal:  World Allergy Organ J       Date:  2021-04-13       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.